Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc. (CYCC) is a publicly traded company in the Unknown sector. Across all available filings, 31 corporate insiders have executed 242 transactions totaling $22.8M, demonstrating a bullish sentiment with $7.7M in net insider flow. The most recent transaction on Sep 5, 2025 involved a sale of 19,054 shares valued at $133.6K.
CYCC Insider Activity Summary
Who Is Buying CYCC Stock?
No significant insider buying has been recorded for CYCC in the recent period.
Who Is Selling CYCC Stock?
No significant insider selling has been recorded for CYCC in the recent period.
Is Cyclacel Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CYCC is bullish with an Insider Alignment Score of 67/100 and a net flow of $7.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CYCC Frequently Asked Questions
Understanding CYCC Insider Activity
Insider trading at Cyclacel Pharmaceuticals, Inc. (CYCC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 31 insiders are actively trading CYCC stock, having executed 242 transactions in the past 90 days. The most active insider is Stanley Morgan (Executive), who has made 79 transactions totaling $14.3M.
Related Tools
Track Cyclacel Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at CYCC file new Form 4 transactions